India, May 28 -- Shares of iTeos Therapeutics, Inc. (ITOS) jumped over 22% on Wednesday morning after the clinical-stage biopharmaceutical company announced its intention to wind down operations.
ITOS is currently trading at $10.41, up $1.88 or 22.00%, on a heavy volume of 6.6 million shares, above average volume of 0.9 million, on the Nasdaq. The stock opened its trading at $10.65 after closing Tuesday at $8.53. The stock has traded between $4.80 and $18.13 in the past 52-week period.
iTeos Therapeutics announced its intention to wind down its operations as part of a comprehensive review of strategic alternatives aimed at maximizing shareholder value.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
...